Parallel, a multi-state cannabis operator, announced the permanent closure of two Florida facilities located in Wimauma and Lakeland, resulting in 211 job losses. The facility closures began on July 6 or during the following 14-day period, according to a Worker Adjustment and Retraining Notification filing reviewed by TheStreet. Affected positions at the facilities included cultivation technicians, production technicians, processing technicians, laboratory workers, and supervisors. At the Wimauma location, among the largest groups impacted were 43 Production Technician I employees, 27 cultivation technicians, and 12 production team leads. The Lakeland facility closure affected 22 cultivation technicians, 5 cultivation team leads, and workers in harvesting, pest management, and research and development roles.
Parallel operates through multiple brands across the United States, including Surterra Wellness in Florida with 45 retail locations, NETA in Massachusetts, and Goodblue in Texas. The company is a vertically integrated cannabis business engaged in cultivation, manufacturing, and retail operations. Employees at the closed facilities were placed on paid administrative leave beginning July 6 and were expected to continue receiving regular compensation and benefits through their termination dates without being required to report to work.
The facility closures coincide with Parallel’s ongoing financial restructuring involving creditors affiliated with SunStream Bancorp, a cannabis-investment joint venture in which Canadian cannabis company SNDL holds an interest. The process involves a strict foreclosure agreement that would transfer certain Parallel assets to creditors to satisfy outstanding debt. The Florida Department of Health approved the license transfer in February 2025, and SNDL indicated expectations for the restructuring process to close in the third quarter of 2026, subject to final regulatory approvals and completion of remaining conditions.
The closures occur within a broader cannabis industry landscape marked by significant projected growth. Global cannabis market valuations reached $102.72 billion in 2025, with projections to reach $137.67 billion in 2026, according to Fortune Business Insights. However, individual operators face challenging conditions including pricing competition, high production costs, varying state regulations, and federal tax restrictions. Recent earnings reports from SNDL indicated revenue declines in cannabis operations, reflecting softer demand and inventory adjustments across the sector.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI